JPRN-UMIN000040341已完成未知
Immunological efficacy of Qing Fei Pai Du Tang for COVID-19: an open-label, single-arm trial - COVID-19/Qing Fei Pai Du Tang
Administration Department, Takanawa Clinic0 个研究点目标入组 18 人开始时间: 2020年5月9日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Current infectious, inflammatory, or immune-related diseases
研究者
相似试验
招募中
1 期
Efficacy and immune mechanism of QingfeiTongluo prescriptions intervention on Mycoplasma pneumoniae pneumonia in childreMycoplasma pneumoniae pneumoniaITMCTR1900002750Tianjin Nankai Hospital
已完成
不适用
Immunological efficacy of Jinhua Qinggan Granule for COVID-19COVID-19JPRN-UMIN000040407Administration Department, Takanawa Clinic18
尚未招募
1 期
The Study of Qi Zhu fang Fomula Improves the Immune Microenvironment Related to Breast Cancer Macrophages: a randomized, double-blind, placebo-controlled studyBreast CancerITMCTR2200005630Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine
已完成
不适用
Investigation of clinical efficacy of Qing-Dai for patients with crohn's disease who have the loss of responsiveness for anti-TNF agentss diseaseCrohn's diseaseJPRN-UMIN000019249Division of Gastroenterology and Hepatology, School of Medicine, Keio University10
招募中
不适用
Efficacy and safety of Qingfei Paidu Decoction (Granules) in the treatment of COVID-19ovel Coronavirus Pneumonia (COVID-19)ITMCTR2100004270Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences